与神经抗体相关的非神经瘤性中枢神经系统疾病中的运动症状
1Neurology Service, Hospital Clínic of Barcelona, Barcelona, Spain.
Handbook of clinical neurology
|August 24, 2023
概括
神经自身抗体与具有常见运动症状的中枢神经系统疾病有关. 本综述将这些疾病分为五组,详细说明其临床特征和运动症状流行率.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 神经免疫学 神经免疫学
背景情况:
- 非神经瘤性中枢神经系统 (CNS) 疾病经常表现为运动症状.
- 神经自身抗体与一系列中枢神经系统疾病有关,影响运动功能.
- 了解这些抗体相关疾病对于诊断和管理至关重要.
研究的目的:
- 将与神经抗体相关的中枢神经系统疾病分为不同的组.
- 描述这些疾病的临床特征,强调运动症状.
- 突出每个类别的运动症状的频率和类型.
主要方法:
- 审查与神经抗体相关的中枢神经系统疾病的五个已确定的组的临床特征.
- 基于抗体点 (突触,细胞内,质等) 的分类. 和受影响的中枢神经系统地区.
- 强调运动症状的存在,频率和特征.
主要成果:
- 鉴定出了五大类抗体相关的中枢神经系统疾病,包括自身免疫性脑炎,小脑,人综合征/渐进性脑筋炎,质抗体相关疾病和睡眠功能障碍.
- 运动症状是大多数这些疾病中占主导的特征.
- 特定的抗体标和受影响的中枢神经系统区域与不同的临床表现和运动缺陷相关.
结论:
- 与神经抗体相关的中枢神经系统疾病代表了一大批神经疾病.
- 基于抗体目标的分类有助于了解临床谱,特别是运动症状.
- 对这些神经免疫学疾病的进一步研究是有必要的,以改善治疗策略.
相关概念视频
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Myasthenia Gravis: Diagnostic Tests
1.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.0K
Myasthenia Gravis: Overview and Treatment
1.6K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.6K
Parkinson's Disease: Overview
596
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
596
Disorders of the Nervous Tissue
1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Parkinson's Disease: Treatment
297
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
297


